Package 75834-124-05

{"route": ["ORAL"], "spl_id": "bdd7c1ab-7f2d-43b5-9ff7-238aa1b9576f", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0375834124018"], "unii": ["X4HES1O11F"], "rxcui": ["197310"], "spl_set_id": ["1b0919aa-0d41-4c91-9ef4-049ac9e27d78"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Nivagen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (75834-124-01)", "package_ndc": "75834-124-01", "marketing_start_date": "20161015"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (75834-124-05)", "package_ndc": "75834-124-05", "marketing_start_date": "20161015"}], "brand_name": "Acyclovir", "product_id": "75834-124_bdd7c1ab-7f2d-43b5-9ff7-238aa1b9576f", "dosage_form": "CAPSULE", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "75834-124", "generic_name": "Acyclovir", "labeler_name": "Nivagen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/1"}], "application_number": "ANDA201445", "marketing_category": "ANDA", "marketing_start_date": "20161015", "listing_expiration_date": "20261231"}